Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beatrice Bilò

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Allergy and Clinical Immunology|July 20, 2002
Epidemiology of Hymenoptera allergyLeonardo Antonicelli, M Beatrice Bilò, Floriano Bonifazi
Current Opinion in Allergy and Clinical Immunology|April 23, 2010
Purified vs. nonpurified venom immunotherapyM Beatrice Bilò, Leonardo Antonicelli, Floriano Bonifazi
Immunotherapy|December 1, 2012
Honeybee venom immunotherapy: certainties and pitfallsM Beatrice Bilò, Leonardo Antonicelli, Floriano Bonifazi
Nutrition and Health|May 16, 2024
Implementation of evidence-based medicine in dietetic practice: Current status and hurdles in ItalyLicia Carnaroli, Matteo Martini, Mariateresa Di Taranto, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 7, 2024
Should Patients With a Large Local Reaction Be Offered Venom Immunotherapy? A Pro-Con DebateM Beatrice Bilò, David B K Golden, M Chiara Braschi, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2009
Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergyFranziska Ruëff, M Beatrice Bilò, Marek Jutel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2020
Safety and Adherence to Venom Immunotherapy During COVID-19 PandemicM Beatrice Bilò, M Chiara Braschi, Mario A Piga, et al.
Journal of Allergy|January 31, 2012
Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrationsM Beatrice Bilò, Barbara Cinti, M Feliciana Brianzoni, et al.
Allergy|December 6, 2024
Real-World Finetuning of Biomarkers in Severe Asthma: Longitudinal Latent Class Analysis From the Italian Registry on Severe Asthma (IRSA)M Beatrice Bilò, Matteo Martini, Leonardo Antonicelli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 12, 2009
The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extractsM Beatrice Bilò, Maurizio Severino, Marcello Cilia, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Allergy and Clinical Immunology|July 20, 2002
Epidemiology of Hymenoptera allergyLeonardo Antonicelli, M Beatrice Bilò, Floriano Bonifazi
Current Opinion in Allergy and Clinical Immunology|April 23, 2010
Purified vs. nonpurified venom immunotherapyM Beatrice Bilò, Leonardo Antonicelli, Floriano Bonifazi
Immunotherapy|December 1, 2012
Honeybee venom immunotherapy: certainties and pitfallsM Beatrice Bilò, Leonardo Antonicelli, Floriano Bonifazi
Nutrition and Health|May 16, 2024
Implementation of evidence-based medicine in dietetic practice: Current status and hurdles in ItalyLicia Carnaroli, Matteo Martini, Mariateresa Di Taranto, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 7, 2024
Should Patients With a Large Local Reaction Be Offered Venom Immunotherapy? A Pro-Con DebateM Beatrice Bilò, David B K Golden, M Chiara Braschi, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2009
Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergyFranziska Ruëff, M Beatrice Bilò, Marek Jutel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2020
Safety and Adherence to Venom Immunotherapy During COVID-19 PandemicM Beatrice Bilò, M Chiara Braschi, Mario A Piga, et al.
Journal of Allergy|January 31, 2012
Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrationsM Beatrice Bilò, Barbara Cinti, M Feliciana Brianzoni, et al.
Allergy|December 6, 2024
Real-World Finetuning of Biomarkers in Severe Asthma: Longitudinal Latent Class Analysis From the Italian Registry on Severe Asthma (IRSA)M Beatrice Bilò, Matteo Martini, Leonardo Antonicelli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 12, 2009
The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extractsM Beatrice Bilò, Maurizio Severino, Marcello Cilia, et al.
Pageof 2